Chongqing Zhifei Biological Products Co Ltd SZSE:300122:
SAYS Q3 NET LOSS AT 601.1 MILLION YUAN ($84.39 million)
($1 = 7.1230 Chinese yuan renminbi)
Zhifei Biological Products' Q3 Net Loss At 601.1 Million Yuan
Earlier from Chongqing Zhifei Biological Products Co., Ltd. Class A
- Chongqing Zhifei Biological Products Co: Revenue and profit declined sharply, but R&D and cash flow remained robust
- Chongqing Zhifei Biological Products Co: Q1 2025 saw a sharp revenue drop and net loss amid weak sales and rising costs
- Chongqing Zhifei Biological Products Co: 2024 saw a 50%+ drop in revenue and profit, prompting a strategic focus on R&D and resilience
- Chongqing Zhifei Biological Products Co: Revenue and profit plunged amid weak sales, negative cash flow, and rising short-term debt